Time and Frequency of Hemodialysis

U.S. Renal Data System. 1991 Annual data report. The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 1991.

Raj D.S.C. , Ramachandran S. , Somiah S. , Mani K. , Dominic S.S. . Quenching the thirst in dialysis patients. Nephron 1996; 73: 597–600.

Lysaght M.J. . Turning points: Hemodialysis membranes. Dial Transplant 1996; 657–9.

Hull A.R. , Parker T.F. 3rd and Dallas Nephrology Associates. Proceedings from the Morbidity, Mortality and Prescription of Dialysis symposium, Dallas, TX, September 15 to 17, 1989. Am J Kidney Dis 1990; 15: 375–83.

Five year survival for end-stage renal disease patients in United States, Europe and Japan, 1982 to 1987. Am J Kidney Dis 1990; 15: 451–7.

United States Renal Data System. Characteristics of dialysis prescription in US, 1987; USRDS 1992 Annual Data Report, Bethesda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases 1992; 29–35.

Valderrabano F. . Weekly duration of dialysis treatment - does it matter for survival? Nephrol Dial Trap 1996; 11: 569–72.

Shaldon S. , Koch K.M. . Survival and adequacy in long term hemodailysis. Nephron 1991; 59: 353–7.

Held P.J. , Blagg C.R. , Liska D.W. , Port F.K. , Hakim R.M. , Levin N.W. . The dose of hemodialysis according to dialysis prescription in Europe and the US. Kidney Int 1992; 42(suppl.): S16–21.

Held P.J. , Garcia J.R. , Mark B.S. , Pauly V. , Cahn M.A. . Price of dialysis, unit staffing and length of dialysis treatments. Am J Kidney Dis 1990; 15: 441–50.

Sargent J.A. . Control of dialysis by a single-pool urea model: the National Cooperative Dialysis Study. Kidney Int 1983 (suppl); S19–25.

Gotch F.A. , Yarian S. , Keen M. . A kinetic survey of US hemodialysis prescription. Am J Kidney Dis 1990; 15: 511–5.

US Renal Data System. Patient mortality and survival. Am J Kidney Dis 1998; 32(suppl.): S69–80.

US Renal Data System. Treatment modalities for ESRD patients. Am J Kidney Dis 1998; 32(suppl.): S50–9.

Charra B. , Calemard E. , Ruffet M. . Survival as an index of adequacy of dialysis. Kidney Int 1992; 41: 1286–91.

Hombrouckx R.O. . Will daily home hemodialysis be an important future therapy for end-stage renal disease? Semin Dial 1995; 8: 270–2.

Buoncristiani U. , Quintaliani G. , Cozzari M. , Giombini L.R.M. . Daily dialysis: Long term clinical and metabolic results. Kidney Int 1998; 24(suppl.): S137–40.

Pierratos A. , Ouwendyk M. , Vas S. . Nocturnal hemodalysis: Three years experience. J Am Soc Nephrol 1198; 9: 859–68.

Charra B. , Calemard M. , Laurent G. . Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996; 16: 35–44.

Buoncristiani U. , Glombini L. , Cozzari M. , Carobi C. , Quintaliani G. , Brugnano R. . Daily recycled bicarbonate dialysis with polyacrylonitrile. Am Soc Artif Intern Organs 1983; 29: 669–72.

Buoncristiani U. , Fagugli R.M. , Pinciaroli M.R. , Kulurianu H. , Ceravolo G. , Bova C. . Reversal of left-ventricular hypertrophy in uremic pateints by treatment with daily hemodialysis (DHD). Contrib Nephrol 1996; 119: 152–6.

Blagg C.R. . A brief history of home hemodialysis. Adv Renal Replace Ther 4–1996; 6: 99–105.

Uldall R. , Ouwendydk M. , Francoeur R. . Slow nocturnal home hemodialysis at the Wellesley Hospital. Adv Renal Replace 1996; 3: 133–6.

Chazot C. , Charra B. , Laurent G. . Interdialysis blood pressure control by long haemodialysis sessions. Nephrol Dial Transplant 1995; 10: 831–7.

Woods J.D. , Port F.K. , Stannard D. , Blagg C.R. , Held P.J. . Comparison of mortality with home hemodialysis and center hemodialysis: A national study. Kidney Int 1996; 49: 1464–70.

Mailloux L.U. , Kapikian N. , Napolitano B. . Home hemodialysis: patient outcomes during a 24-year period of time from 1970 through 1993. Advances in Renal Replace Ther 4-1996; 3: 112–9.

Vanholder R.C. , Ringoir S.M. . Adequacy of dialysis. A critical analysis. Kidney Int 1992; 42: 540–58.

Vanholder R. , De Smet R. , Hsu C. , Vogeleere P. , Ringoir S. . Uremic toxicity: The middle molecule weight hypothesis revisited. Semin Nephrol 1994; 14: 205–18.

Charra B. , Calemard E. , Chazot C. . Dose of dialysis: what index? Blood Purif 1992; 10: 13–21.

Raj D.S.C. , Ouwendyk M. , Francoeur R. , Vas S. , Uldall R. , Pierratos A. . Beta 2 microglobulin removal by slow nocturnal hemodialysis. (Abstract) A promise for prevention of dialysis related amyloidosis. J Am Soc Nephrol 1996; 7: 1495.

O'Sullivan D.A. , McCarthy J.T. , Kimar R. , Williams A.W. . An examination of the safety and efficacy of slow nocturnal hemodialysis (Abstract). J Am Soc Nephrol 1997; 8: 168–9.

Babb A.L. , Popovich R.P. , Christopher T.G. , Scribner B.H. . The genesis of square meter hour hypothesis. Trans Am Soc Artif Organs 1971; 17: 81–91.

Babb A.L. , Strand M.J. , Uvelli D.A. , Scribner B.H. . The dialysis index: A practical guide to dialysis treatment. Dialysis Transplant 1996; 25: 633–44.

Charra B. , Laurent G. , Calemard E. . Survival in dialysis and blood pressure control. Contrib Nephrol 1994; 106: 179–85.

Odell R.A. , Slowiaczek P. , Moran J.E. , Schindhelm K. . Beta 2-microglobulin kinetics in end-stage renal failure. Kidney Int 1991; 39: 909–19.

Lindsay R.M. , Spanner E. , Heidenheim R.P. . Which comes first, Kt/V or PCR-chicken or egg? Kidney Int 1992; 38(suppl.): S32–6.

Floge J. , Granolleras C. , Bingel M. . Beta 2-microglobulin kinetics during hemodialysis and haemofiltration. Nephrol Dial Transplant 1987; 1: 223–8.

Charra B. , Calemard E. , Laurent G. . Chronic renal failure treatment duration and mode: their relevance to the late dialysis periarticular syndrome. Blood Purif 1988; 6: 117–24.

Chazot C. , Chazot I. , Charra B. . Functional study of hands among patients dialysed for more than 10 years. Nephrol Dial Transplant 1993; 8: 347–51.

Hakim R.M. , Wingard R.L. , Husni L. , Parker R.A. , Parker T.F. . The effect of membrane biocompatibility on plasma beta 2-microglobulin levels in chronic hemodialysis patients. J Am Soc Nephrol 3-1996; 7: 472–8.

Floege J. , Schaffer J. , Koch K.M. , Shaldon S. . Dialysis related amyloidosis: a disease of chronic retention and inflammation? (Review). Kidney Int 1992; 38(suppl.): S78–85.

Zucchelli P. , Santoro A. . Inorganic phosphate removal during different dialytic procedures. Int J Artif Organs 1987; 10: 173–8.

Musci I. , Hercz G. , Uldall P.R. , Ouwendyk M. , Francoeur R. , Pierratos A. . Control of serum phosphate without any phosphate binders in patients treated with nocturnal dialysis. Kidney Int 1998; 53: 1399–404.

Gotch F.A. , Sargent J.A. . A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985; 28: 526–34.

Keshaviah P. . Urea kinetic and middle molecule approaches to assessing the adequacy of hemodialysis and CAPD. (Review). Kidney Int 1993; 40(suppl.): S28–38.

Collier A. , Liao M. , Umen A. , Hansen G , Keshaviah P. . Diabetic hemodialysis patients treated with a higher Kt/V have lower risk of death than standard Kt/V. J Am Soc Nephrol 1991; 2: 318.

Lindsay R.M. , Heidenheim A.P. , Spanner E. , Kortas C. , Blake P.G. . Adequacy of hemodialysis and nutrition-important determinants of morbidity and mortality. Kidney Int 1994; 45(suppl.): S85–91.

Lopot F. , Valek A. . The time averaged concentration-time averaged deviation: a new concept in mathematical assesment of dialysis adequacy. Nephrol Dial Transplant 1988; 3: 846–8.

Haraldsson B. . Higher Kt/V is needed for adequate dialysis if the treatment time is reduced. Insights from a blood flow distribution model. Nephrol Dial Transplant 1995; 10: 1845–51.

Depner T.A. . Daily hemodialysis. A quantitative perspective. Semin Dial 1995; 8: 315–17.

Descombes E. , Hanck A.B. , Fellay G. . Water soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int 6-1993; 43: 1319–28.

Langos V. , Ecclestone A. , Lum D. . Slow nocturnal hemodialysis: Nutritional aspects (Abstract). J Am Soc Nephrol 1996; 7: 1518.

Kjellstrand C.M. , Rosa A.A. , Shideman J.R. , ROdrigo F. , Davin , Lynch R.E. . Optimal dialysis frequency and duration: the “unphysiology hypothesis”. Kidney Int 1978; 6: (suppl) S120–4.

Keshaviah P.R. , Nolph K.D. . The peak concentration hypothesis: A kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis and hemodialysis. Perit Dial Int 1989; 9: 257–60.

Pedrini L.A. , Zereik S. , Rasmy S. . Causes kinetics and clinical implications of post-hemodialysis urea rebound. Kidney Int 1988; 34: 817–24.

Leypoldt J.K. . Dialyzers and dialysis membranes, research directions. ASAIO J 1996; 133–5.

Locatelli F. , Mastrangelo F. , Redaelli B. , The Italian Cooperative Dialysis Study Group, et al. Effect of different membranes and dialysis technologies on patient tolerance and nutritional parameters. Kidney Int 1996; 50: 1293–302.

Hakim R.M. , Held P.J. , Stannard D.C. . Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 1996; 50: 566–70.

Gutierrez A. , Bergstrom J. , Alvestrand A. . Protein catabolism in sham-hemodialysis: the effect of different membranes. Clin Nephrol 1992; 38: 20–9.

Koda Y. , Nishi S. , Miyazaki S. . Switch from conventional to high flux membrane reduces the risk of carpal tunnel syndrome and mortality in hemodialysis patietns. Kidney Int 1997; 52: 1096–101.

Vanholder R. , Van Loo A. , Dhondt M. , Ringoir S. . The role of dialysis membranes in infection. Nephrol Dial Transplant 1996; 11: 101–3.

Lindsay R.M. , Spanner E. . A hypothesis: the protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients. Am J Kidney Dis 1989; 13: 382–9.

Henderson L.W. , Cheung A.K. , Chenoweth D.E. . Choosing a membrane. Am J Kidney Dis 1983; 111: 5–20.

Dinarello C. . Cytokines: Agents provocateurs in hemodialysis? Kidney Int 1992; 41: 683–94.

Health Care Financing Administration. End-stage Renal Disease Program Highlights 1994/1995.

Evans R.W. , Manninen D.L. , Garrison L.P. . Quality of life of patients with end-stage renal disease. N Engl J Med 1985; 312: 553–9.

Rasgon S. , Rogers A.J. , Chemleski B. . Maintenance of employment on dialysis. Adv Renal Replace 1997; 4: 152–9.

Verdecchia P. , Schillaci G. , Guerrieri M. . Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension (see comments). Circulation 2-1990; 81: 528–36.

Covic A. , Goldsmith D.J. , Georgescu G. , Venning M.C. , Acrill P. . Echocardiographic findings in long-term, long-hour hemodialysis patients. Clinical Nephrol 2-1996; 45: 104–10.

Acchiardo S.R. , Moore L.W. , Latour P.A. . Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 1983; 16(suppl.): S199–203.

Raj D.S.C. , Tobe S.W. , Saiphoo C.S. , Manuel M.A. . Mass balance index an index for adequacy of dialysis and nutrition. Int J Artif Organs 1998; 21: 328–34.

Lowrie E.G. , Lew N.L. . Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458–82.

Bergstrom J. , Alvestrand A. , Furst P. . Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition. Kidney Int 1990; 38: 108–14.

Raj D.S.C. , Ouwendyk M. , Francoeur R. , Logos V. , Ecclestone A. , Pierratos A. . Amino acid profile in nocturnal hemodialysis (Abstract). J Am Soc Nephrol 1997; 8: 170.

Silberbeg J.S. , Barre P.E. , Prichard S.S. , Sniderman A.D. . Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286–90.

US Renal Data System. USRDS Annual data report, The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis 1998; 32(suppl.): S81–8.

Schneditz D. , Roob J. , Oswald M. . Nature and rate of vascular refilling during hemodialysis and ultrafiltration. Kidney Int 1992; 42: 1425–33.

Held P.J. , Levin N.W. , Bovberg R.R. , Pauly M.V. , Diamond L.H. . Mortality and duration of hemodialysis treatment. JAMA 1991; 265: 871–5.

Abuyelo J.G. , Shemin D. , Chazan J.A. . Acute symptoms produced by hemodialysis. A review of their causes and associations. Semin Dial 1993; 6: 59–69.

Capuano A. , Sepe V. , Cianfrone P. , Castellano T. , Andreucci V.E. . Cardiovascular impairment, dialysis strategy and tolerance in elderly and young patients on maintenance hemodialysis. Nephrol Dial Transplant 1990; 4: 1023–30.

Wizemann V. . Present clinical experience and future aspects hemodiafilterazion. In: Cambi V. ed. Short dialysis. Boston: Nijhoff 1987; 293–320.

Buoncristiani U. , Fagugli R.M. , Ciaco G. , Cicconi B. , Ciucci A. , Quintaliani G. . Left ventricular hypertrophy reduction in hypertensive patients on daily hemodialysis. (Abstract) J Am Soc Nephrol 1998; 9: 232.

Pierratos A. , Thornley K. , Ouwendyk M. , Francoeur R. , Hanly P. . Nocturnal hemodialysis improves sleep quality in patients with chronic renal failure (Abstract). J Am Soc Nephrol 1997; 8: 169.

Buoncristiani U. , Fagugli R.M. , Cantelmi M.G. , Covarelli C. . Daily hemodialysis effectively lowers hyperhomocysteinemia in uremic patients (Abstract). J Am Soc Nephrol 1998; 9: 233.

Ritz E. , Vallance P. , Nowicki M. . The effect of malnutrition on cardiovascular mortality in dialysis patients. Is L-argenine the answer? Nephrol Dial Transplant 1994; 9: 129–30.